Roundhill GLP-1 & Weight Loss ETF is a ETF series of Roundhill ETF Trust (series S000085000). Net assets $51.4M as of 2026-03-31.
Showing 15 of 27 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly & Co | — | $8.3M | 1609.80% |
| Novo Nordisk A/S | — | $6.8M | 1313.37% |
| Mount Vernon Liquid Assets Portfolio, LLC | — | $6.2M | 1213.69% |
| Pfizer Inc | — | $3.9M | 755.61% |
| Viking Therapeutics Inc | — | $2.7M | 528.65% |
| Innovent Biologics Inc | — | $2.6M | 510.50% |
| Ascletis Pharma Inc | — | $2.4M | 467.48% |
| Amgen Inc | — | $2.0M | 394.13% |
| Roche Holding AG | — | $2.0M | 391.79% |
| AstraZeneca PLC | — | $1.9M | 376.46% |
| Hanmi Pharm Co Ltd | — | $1.9M | 365.59% |
| Zealand Pharma A/S | — | $1.9M | 359.77% |
| Chugai Pharmaceutical Co Ltd | — | $1.8M | 345.14% |
| Regeneron Pharmaceuticals Inc | — | $1.7M | 333.15% |
| FOSUN PHARMA | — | $1.7M | 325.59% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $51.4M |
| 2025-12-31 | $44.3M |
| 2025-09-30 | $34.3M |
| 2025-06-30 | $33.2M |
| 2025-03-31 | $37.1M |
| 2024-12-31 | $39.8M |
| 2024-09-30 | $45.6M |
| 2024-06-30 | $33.0M |